LAROTRECTINIB

847 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAROTRECTINIB:

# Side effect Count
0 FATIGUE 61
1 DRUG INEFFECTIVE 59
2 DIZZINESS 53
3 DEATH 50
4 NEUROPATHY PERIPHERAL 43
5 PAIN 42
6 NAUSEA 38
7 OFF LABEL USE 36
8 DISEASE PROGRESSION 33
9 MYALGIA 26
See all common reactions for LAROTRECTINIB

LAROTRECTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NTRK GENE FUSION POSITIVE 1 0.5000
1 NTRK GENE FUSION OVEREXPRESSION 1 0.5000
2 NTRK GENE FUSION CANCER 2 0.5000
3 MALIGNANT NEOPLASM OF RETINA 1 0.3333
4 CONGENITAL FIBROSARCOMA 1 0.3333
5 NASAL ASPIRATION 1 0.2500
6 FIBROSARCOMA METASTATIC 1 0.1250
7 MESOBLASTIC NEPHROMA 1 0.1250
8 SALIVARY GLAND CANCER RECURRENT 1 0.0667
9 ADENOCARCINOMA OF SALIVARY GLAND 2 0.0513
See all enriched reactions for LAROTRECTINIB